A phase I trial of gemcitabine, carboplatin or gemcitabine, paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: An RTOG study.

被引：0
|
作者：
Choy, H
Swann, S
Walter, C
Whipple, G
Demas, W
Ettinger, D
机构：
[1] Univ Texas, SW Med Ctr Dallas, Dallas, TX 75235 USA
[2] Amer Coll Radiol, Philadelphia, PA USA
[3] Thomas Jefferson, Philadelphia, PA USA
[4] LDS Hosp, Salt Lake City, UT USA
[5] Sunma Hlth Syst, Akron, OH USA
[6] Johns Hopkins, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：646S / 646S
页数：1
相关论文
共 50 条
  • [1] A phase I trial of gemcitabine, carboplatin or gemcitabine, paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small call lung cancer: An RTOG study
    Swann, S
    Choy, H
    Walter, C
    Whipple, G
    Demas, W
    Ettinger, D
    LUNG CANCER, 2005, 49 : S270 - S271
  • [2] A phase I trial of gemcitabine, carboplatin or gemcitabine, paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: An RTOG 0017 study
    Choy, H
    Swann, S
    Curran, W
    Whipple, G
    Demas, W
    Ettinger, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S42 - S43
  • [3] RTOG 0017: A Phase I Trial of Concurrent Gemcitabine/Carboplatin or Gemcitabine/Paclitaxel and Radiation Therapy ("Ping-Pong Trial") Followed By Adjuvant Chemotherapy for Patients with Favorable Prognosis Inoperable Stage IIIA/B Non-small Cell Lung Cancer
    Choy, Hak
    Jain, Anshit K.
    Moughan, Jennifer
    Curran, Walter
    Whipple, Gary
    Demas, William F.
    Ettinger, David S.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (01) : 80 - 86
  • [4] Phase II study of weekly carboplatin/gemcitabine plus concurrent thoracic radiotherapy (RT) followed by consolidation carboplatin/gemcitabine for inoperable stage III non-small cell lung cancer (NSCLC).
    Domine, Manuel
    Carames Sanchez, Cristina
    Lobo, Francisco
    Hernandez Guerrero, Tatiana Carolina
    Leon, Ana
    Casado, Victoria
    Rubio, Gustavo
    Ignacio Martin-Valades, Jose
    Izarzugaza, Yann
    Luis Arranz, Juan
    Moreno, Irene
    Correa Noguera, Andrea
    Zenzola, Victor
    Dorta, Miriam
    Casado, Susana
    Ruperez, Ana
    Hernandez Lopez, Roberto
    Moreno, Victor
    Garcia-Foncillas, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Phase II trial with carboplatin/gemcitabine induction chemotherapy followed by radiotherapy concomitantly with paclitaxel/gemcitabine in stage III non-small cell lung cancer (NSCLC).
    Hirsh, V.
    Duclos, M.
    Souhami, L.
    Del Vecchio, P.
    Ofiara, L.
    Faria, S.
    Ayoub, J.
    Charpentier, D.
    Portelance, L.
    Soulieres, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 398S - 398S
  • [6] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
  • [7] A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer
    Argiris, A
    Liptay, M
    LaCombe, M
    Marymont, M
    Kies, MS
    Sundaresan, S
    Masters, G
    LUNG CANCER, 2004, 45 (02) : 243 - 253
  • [8] Induction carboplatin/paclitaxel/gemcitabine (CPG) followed by concurrent weekly carboplatin/paclitaxel (CP) and radiation therapy in unresectable stage III non small cell lung cancer (NSCLC).
    Oniga, F
    Paccagnella, A
    Fasan, S
    Ardit, S
    Gatti, C
    Biason, R
    Medici, M
    D'Amanzo, P
    Ghi, MG
    Nascimben, O
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 703S - 703S
  • [9] Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)
    Kosmidis, PA
    Kalofonos, C
    Syrigos, K
    Skarlos, D
    Fountzilas, G
    Nicolaides, C
    Bafaloukos, D
    Samantas, E
    Bakogiannis, C
    Dimopoulos, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 621S - 621S
  • [10] Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)
    Kosmidis, P
    Kalofonos, C
    Syrigos, K
    Skarlos, D
    Fountzilas, G
    Nicolaides, C
    Bafaloukos, D
    Samantas, E
    Bakogiannis, C
    Dimopoulos, A
    LUNG CANCER, 2005, 49 : S34 - S34
12345